Correlation Between Bristol Myers and Biora Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Biora Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Biora Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Biora Therapeutics, you can compare the effects of market volatilities on Bristol Myers and Biora Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Biora Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Biora Therapeutics.
Diversification Opportunities for Bristol Myers and Biora Therapeutics
-0.81 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Bristol and Biora is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Biora Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biora Therapeutics and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Biora Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biora Therapeutics has no effect on the direction of Bristol Myers i.e., Bristol Myers and Biora Therapeutics go up and down completely randomly.
Pair Corralation between Bristol Myers and Biora Therapeutics
Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.26 times more return on investment than Biora Therapeutics. However, Bristol Myers Squibb is 3.86 times less risky than Biora Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Biora Therapeutics is currently generating about -0.11 per unit of risk. If you would invest 6,049 in Bristol Myers Squibb on September 2, 2024 and sell it today you would lose (127.00) from holding Bristol Myers Squibb or give up 2.1% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bristol Myers Squibb vs. Biora Therapeutics
Performance |
| Timeline |
| Bristol Myers Squibb |
| Biora Therapeutics |
Bristol Myers and Biora Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bristol Myers and Biora Therapeutics
The main advantage of trading using opposite Bristol Myers and Biora Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Biora Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biora Therapeutics will offset losses from the drop in Biora Therapeutics' long position.| Bristol Myers vs. AbbVie Inc | Bristol Myers vs. Merck Company | Bristol Myers vs. Gilead Sciences | Bristol Myers vs. Johnson Johnson |
| Biora Therapeutics vs. Enveric Biosciences | Biora Therapeutics vs. Elevation Oncology | Biora Therapeutics vs. Hepion Pharmaceuticals | Biora Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |